AIMT
Aimmune Therapeutics, Inc.
AIMT
AIMT
Delisted
AIMT was delisted on the 12th of October, 2020.
100 hedge funds and large institutions have $925M invested in Aimmune Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+4
Holders Change %
+4.17%
% of All Funds
2.5%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.1%
New
12
Increased
38
Reduced
28
Closed
8
Calls
$11.4M
Puts
$1.24M
Net Calls
+$10.2M
Net Calls Change
+$9.93M
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$13.9M |
| 2 |
2
UBS AM
Chicago,
Illinois
|
$7.21M |
| 3 |
3
BlackRock
New York
|
$68.7M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$65M |
| 5 |
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$5.65M |
